I know...I'm not an internet bro either. I have read your posts and I know when I see someone who is well-versed and educated in subjects. However, to sit there are say Meriva is the best and most-backed when it supposedly has no clinical research in humans is odd. BCM-95 looks like the world-beater in these graphs and charts...but also supposedly has no human trials. From what I heard on that webinar....the choice of the M.D. and the only one which has backing with human trials is Longvida. Sabinsa C3 it out there....so it Theracurmin...and even Curcuclear. At this point I am not even sure of all the differences in these 6+ kinds....all which fib and twist things to tell you they are superior.
I like your posts bro...you could really add a lot here it seems.
apologies... was having a shitty night when I wrote that and thought you were calling me out haha... That is my bad. Meriva does have clinical research in humans. Here are some publications involving either A) phytosome drug delivery for hydrophilic
An overview of phytosomes as an advancedherbal drug delivery system
An overview of phytosomes as an advanced herbal drug delivery system | Kapil Khambholja - Academia.edu
phytosome drug delivery has enhanced capacity to cross the lipid-rich biomembranes and, finally, reach the blood. They have improved pharmacokinetic and pharmacological parameters.
Product-evaluation registry of Meriva®, a curcumin-phosphatidylcholine complex, for the complementary management of osteoarthritis.
Product-evaluation registry of Meriva®, a cur... [Panminerva Med. 2010] - PubMed - NCBI
- 50 patients with OA used 200 mg curcumin per diem for 3 months and saw benefits in mobility, walking distance, WOMAC scores adn reduction in CRP.
Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study.
Potential role of curcumin phytosome (Meriva)... [Panminerva Med. 2011] - PubMed - NCBI
Now the next one pertains to systemic levels of curcumin after regular curcumin and meriva. This will demonstrate its ability to reach the liver in a significant manner, for which, we can then utilize other studies to speak to its benefits upon the liver.
Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine.
Comparison of systemic availabili... [Cancer Chemother Pharmacol. 2007] - PubMed - NCBI
Curcumin and liver disease.
Curcumin and liver disease. [Biofactors. 2013 Jan-Feb] - PubMed - NCBI
- discusses various liver diseases and the role curcumin can play in it.
So, no, we do not have clinical trials involving specifically liver diseases in humans to my knowledge but we do have is that this specific forumlation is demonstrating efficacy in various diseases states (i left a good amount out because I just wanted to get the point across). This means that is is being taken up and utilized in the body whereever it may be present. Then we have a study demonstrating that it is present in the liver after ingestion. It is present to a much greater level than regular curcumin. We know that curcumin has shown strong hepatoprotective effects in the liver whether that be in-vitro or in-vivo or in animal models. We have a decent understand of the mechanism of action for this hepatoprotective effect as well.
"In vitro and in vivo experiments suggested that curcumin
may play a major role in hepatocytes protection by inhibiting
the production of NO and TNF-a in LPS-activated Kupffer
cells. Later studies using LPS-induced hepatotoxicity further
sustained these findings, highlighting the interfering role of curcumin on the inflammatory and apoptotic TNF-a/NF-jB signaling
pathway"
"Curcumin
treatment has also been shown to decrease hepatic NF-jB levels,
markers of hepatic inflammation, and hepatomegaly in diabetic
and obese mouse models"
"besides TNF-a signaling, curcumin
has been reported to inhibit the expression of other NF-jBdependent
inflammatory chemokines and cytokines, such as
IL-6, IL-2, TGF-b, and MCP-1, and inflammation-promoting
enzymes such as COX-2 and iNOS in Kupffer cells and hepatic
tissue homogenates"
and the informatino continues on and on.
You get the point though. We dont have exact studies in humans for specific disease states of the liver but we do know that it is able to inhibit the expression of various enzymes or inflammatory mediating chemo/cytokines which then in turn will reduce the levels of leukocyte/macrophage/neutrophil migration to the site of inflammatin in the liver, along with a whole slew of other aspects. Lastly, we know this formulation is found int he liver after ingestion and that high levels of demethoxycurcumin are found in the blood serum of volunteers ingesting meriva which is a potent metabolite/curcuminoid .
Apologize for the amount of writing...feel free to ask questinos or pin-point certian aspects that I am no clear on or you don't agree with!